cerebral apoplexy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) 2 weeks to 6 months after the onset of stroke; (2) First onset, unilateral lesion, located in a unilateral subcortical stroke (basal nucleus, thalamus, internal capsule, corona radiata), with motor dysfunction on one side of the upper limb; (3) Voluntarily participate in this clinical trial, and either the individual or their family member signs an informed consent form;
Exclusion criteria
Exclusion criteria: (1) Hemiplegia caused by non cerebrovascular diseases such as traumatic brain injury, brain tumor, and postoperative brain surgery; (2) Individuals with severe organ failure such as heart, lung, liver, and kidney; (3) Individuals with a history of stroke and/or residual limb dysfunction; (4) Poor compliance and failure to follow medical advice for treatment; (5) Individuals with unilateral neglect or blindness; (6) Patients with acupuncture intolerance; Excluding pregnant women; (7) Individuals with a tendency towards bleeding; Patients with brain tumors, arterial malformations, and venous malformations; Individuals with severe heart valve disease, cardioembolic conditions, etc; (8) Patients whose bodies contain metal devices such as pacemakers, stents, and cochlear implants that are not suitable for transcranial magnetic stimulation; (9) There are metal hardware in close contact with the discharge coil, such as cochlear implants, internal pulse generators, or drug pumps. (10) There are electrodes made of silver and gold in the skull, as well as metal brain implants. (11) Patients with electronic components (such as IPG located in the neck or torso) within a distance of less than 10cm from the TMS coil (such as pacemakers, vagus nerve stimulation systems, and spinal cord stimulators) are prohibited from using electronic components within the body. (12) Patients with a distance of less than 10cm between the implanted pulse generator for deep brain stimulation and the transcranial magnetic stimulation coil are prohibited; (13) Having a history of epileptic seizures, frequent headaches, tinnitus, and drug abuse, using anesthetic analgesics in the past two weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fugl-Meyer Assessment-Upper Extremities; | — |
Secondary
| Measure | Time frame |
|---|---|
| modified Barthel Index;Lovett muscle strength grading;d potential (MEP) cortical latency, amplitude, and central motor conduction time; | — |
Countries
People's Republic of China
Contacts
Shanghai University of Traditional Chinese Medicine Affiliated Seventh People's Hospital